124 related articles for article (PubMed ID: 8314305)
21. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
[TBL] [Abstract][Full Text] [Related]
23. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
[TBL] [Abstract][Full Text] [Related]
24. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
25. Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid.
Benbow U; Schoenermark MP; Orndorff KA; Givan AL; Brinckerhoff CE
Clin Exp Metastasis; 1999 May; 17(3):231-8. PubMed ID: 10432008
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms regulating the production of collagenase and TIMP in U937 cells: evidence for involvement of delayed transcriptional activation and enhanced mRNA stability.
Shapiro SD; Doyle GA; Ley TJ; Parks WC; Welgus HG
Biochemistry; 1993 Apr; 32(16):4286-92. PubMed ID: 8476858
[TBL] [Abstract][Full Text] [Related]
27. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
28. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes.
Sasaki K; Hattori T; Fujisawa T; Takahashi K; Inoue H; Takigawa M
J Biochem; 1998 Mar; 123(3):431-9. PubMed ID: 9538225
[TBL] [Abstract][Full Text] [Related]
30. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
31. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.
Sehgal I; Thompson TC
Mol Biol Cell; 1999 Feb; 10(2):407-16. PubMed ID: 9950685
[TBL] [Abstract][Full Text] [Related]
32. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
Korem S; Resnick MB; Kraiem Z
J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
[TBL] [Abstract][Full Text] [Related]
33. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
Hewitt R; Danø K
Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
[TBL] [Abstract][Full Text] [Related]
34. Constitutive release of metalloproteinase-9 (92-kd type IV collagenase) by Kaposi's sarcoma cells.
Blankaert D; Simonart T; Van Vooren JP; Parent D; Liesnard C; Farber CM; Marique T; Werenne J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):203-9. PubMed ID: 9665496
[TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
[TBL] [Abstract][Full Text] [Related]
36. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
Sava G; Capozzi I; Bergamo A; Gagliardi R; Cocchietto M; Masiero L; Onisto M; Alessio E; Mestroni G; Garbisa S
Int J Cancer; 1996 Sep; 68(1):60-6. PubMed ID: 8895542
[TBL] [Abstract][Full Text] [Related]
38. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
39. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
[TBL] [Abstract][Full Text] [Related]
40. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts.
Svendsrud DH; Loennechen T; Winberg JO
Biochem Pharmacol; 1997 May; 53(10):1511-20. PubMed ID: 9260879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
